| Impaired HLA class I antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint inhibitors in lung cancer S Gettinger, J Choi, K Hastings, A Truini, I Datar, R Sowell, A Wurtz, ... Cancer discovery 7 (12), 1420-1435, 2017 | 603 | 2017 |
| Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma KA Schalper, ME Rodriguez-Ruiz, R Diez-Valle, A López-Janeiro, ... Nature medicine 25 (3), 470-476, 2019 | 535 | 2019 |
| Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening BD Stuart, J Choi, S Zaidi, C Xing, B Holohan, R Chen, M Choi, ... Nature genetics 47 (5), 512-517, 2015 | 470 | 2015 |
| EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer K Hastings, HA Yu, W Wei, F Sanchez-Vega, M DeVeaux, J Choi, H Rizvi, ... Annals of Oncology 30 (8), 1311-1320, 2019 | 287 | 2019 |
| Expression analysis and significance of PD-1, LAG-3, and TIM-3 in human non–small cell lung cancer using spatially resolved and multiparametric single-cell analysis I Datar, MF Sanmamed, J Wang, BS Henick, J Choi, T Badri, W Dong, ... Clinical Cancer Research 25 (15), 4663-4673, 2019 | 258 | 2019 |
| CLCN2 chloride channel mutations in familial hyperaldosteronism type II UI Scholl, G Stölting, J Schewe, A Thiel, H Tan, C Nelson-Williams, ... Nature genetics 50 (3), 349-354, 2018 | 228 | 2018 |
| Isolated polycystic liver disease genes define effectors of polycystin-1 function W Besse, K Dong, J Choi, S Punia, SV Fedeles, M Choi, AR Gallagher, ... The Journal of clinical investigation 127 (5), 1772-1785, 2017 | 207 | 2017 |
| Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial–mesenchymal transition S Zhao, S Bellone, S Lopez, D Thakral, C Schwab, DP English, J Black, ... Proceedings of the National Academy of Sciences 113 (43), 12238-12243, 2016 | 205 | 2016 |
| Two locus inheritance of non-syndromic midline craniosynostosis via rare SMAD6 and common BMP2 alleles AT Timberlake, J Choi, S Zaidi, Q Lu, C Nelson-Williams, ED Brooks, ... elife 5, e20125, 2016 | 181 | 2016 |
| Regression of chemotherapy-resistant polymerase ϵ (POLE) ultra-mutated and MSH6 hyper-mutated endometrial tumors with nivolumab AD Santin, S Bellone, N Buza, J Choi, PE Schwartz, J Schlessinger, ... Clinical Cancer Research 22 (23), 5682-5687, 2016 | 173 | 2016 |
| Transcriptome Remodeling in Trypanosoma cruzi and Human Cells during Intracellular Infection Y Li, S Shah-Simpson, K Okrah, AT Belew, J Choi, KL Caradonna, ... PLoS pathogens 12 (4), e1005511, 2016 | 161 | 2016 |
| A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers SN Gettinger, J Choi, N Mani, MF Sanmamed, I Datar, R Sowell, VY Du, ... Nature communications 9 (1), 3196, 2018 | 160 | 2018 |
| De novo mutation in genes regulating neural stem cell fate in human congenital hydrocephalus CG Furey, J Choi, SC Jin, X Zeng, AT Timberlake, C Nelson-Williams, ... Neuron 99 (2), 302-314. e4, 2018 | 123 | 2018 |
| Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling JM Chan, S Zaidi, JR Love, JL Zhao, M Setty, KM Wadosky, A Gopalan, ... Science 377 (6611), 1180-1191, 2022 | 111 | 2022 |
| De novo mutations in inhibitors of Wnt, BMP, and Ras/ERK signaling pathways in non-syndromic midline craniosynostosis AT Timberlake, CG Furey, J Choi, C Nelson-Williams, ... Proceedings of the National Academy of Sciences 114 (35), E7341-E7347, 2017 | 87 | 2017 |
| Comprehensive genetic analysis of follicular thyroid carcinoma predicts prognosis independent of histology NG Nicolson, TD Murtha, W Dong, JO Paulsson, J Choi, AL Barbieri, ... The Journal of Clinical Endocrinology & Metabolism 103 (7), 2640-2650, 2018 | 78 | 2018 |
| Targeted mutagenesis in mouse cells and embryos using an enhanced prime editor SJ Park, TY Jeong, SK Shin, DE Yoon, SY Lim, SP Kim, J Choi, H Lee, ... Genome biology 22 (1), 170, 2021 | 74 | 2021 |
| Mutations in chromatin modifier and ephrin signaling genes in vein of Galen malformation D Duran, X Zeng, SC Jin, J Choi, C Nelson-Williams, B Yatsula, J Gaillard, ... Neuron 101 (3), 429-443. e4, 2019 | 72 | 2019 |
| Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo G Foggetti, C Li, H Cai, JA Hellyer, WY Lin, D Ayeni, K Hastings, J Choi, ... Cancer discovery 11 (7), 1736-1753, 2021 | 66 | 2021 |
| Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy L Zammataro, S Lopez, S Bellone, F Pettinella, E Bonazzoli, E Perrone, ... Proceedings of the National Academy of Sciences 116 (45), 22730-22736, 2019 | 66 | 2019 |
